Measuring the activity or expression levels of signaling molecules (FAS, ATGL, LPL, PPARs, MMPs, α-SMA, and certain indicative proteins) and transcription factors can provide insights into their mechanisms of action in fibrosis, metabolic disorders, and chronic diseases. This evidence concerns the gene PNPLA2 and metabolic disease.